NCT07081815View on ClinicalTrials.gov

JOCOAT Safety and Tolerability Clinical Trial GLAD-04

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Surgical Adhesions
Interventions
DEVICE

JOCOAT(TM) APN-3003

10 mL of JOCOAT(TM) APN-3003 is applied at the end of surgery

Sponsors

Lead Sponsor

ARC Medical Inc.
All Listed Sponsors
lead

ARC Medical Inc.

INDUSTRY